Short answer · Medically reviewed summary · Last updated: 2026-05-08
Melorheostosis is a rare, non-hereditary sclerosing bone dysplasia first described in 1922 by Léri and Joanny, characterized by its signature "dripping candle wax" appearance on radiographs. Over the last century, our understanding of Melorheostosis has shifted from a purely radiographic curiosity to a condition now recognized as being linked to somatic mosaic mutations in the MAP2K1 gene. Who first discovered Melorheostosis? The condition was formally identified in 1922 by French physicians André Léri and Maurice Joanny.
What is the history of Melorheostosis?
History of Melorheostosis: when and how it was discovered, and the milestones in research since, medically reviewed.
Melorheostosis is a rare, non-hereditary sclerosing bone dysplasia first described in 1922 by Léri and Joanny, characterized by its signature "dripping candle wax" appearance on radiographs. Over the last century, our understanding of Melorheostosis has shifted from a purely radiographic curiosity to a condition now recognized as being linked to somatic mosaic mutations in the MAP2K1 gene.
Who first discovered Melorheostosis?
The condition was formally identified in 1922 by French physicians André Léri and Maurice Joanny. They coined the term Melorheostosis, derived from the Greek words melos (limb), rheo (flowing), and osteon (bone), to describe the characteristic hyperostosis that resembles wax flowing down a burning candle. Prior to this, cases were often misdiagnosed as forms of chronic osteomyelitis or syphilis.
How has our understanding of Melorheostosis evolved?
Historically, Melorheostosis was viewed as a static, isolated skeletal anomaly. However, medical literature has evolved to recognize it as a complex, systemic condition that can involve soft tissues, skin, and vascular structures. Modern molecular genetics have been transformative; researchers now understand that Melorheostosis often arises from post-zygotic somatic mutations, specifically in the MAP2K1 gene, which explains why the condition is not inherited and typically affects only one limb (monomelic).
What are the major milestones in research and advocacy?
- 1922: First clinical description by Léri and Joanny.
- 1990s-2000s: Increased usage of MRI and CT imaging, allowing for better distinction between Melorheostosis and other sclerosing bone dysplasias.
- 2018: A landmark study identified somatic MAP2K1 mutations as a primary driver, moving the field into the era of precision medicine.
- Community Growth: Platforms like DiseaseMaps.org have connected 65 people with Melorheostosis, providing a vital space for patients to share experiences and combat the isolation of this rare diagnosis.
Next steps
- Consult an orthopedic specialist or a rheumatologist experienced in bone dysplasias to manage symptoms.
- Join the 65 members on DiseaseMaps.org to share your journey and learn from others living with Melorheostosis.
- Monitor for soft tissue contractures or vascular malformations, which are common complications requiring multidisciplinary care.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Melorheostosis
- Orphanet: Melorheostosis (ORPHA:565)
- OMIM (Online Mendelian Inheritance in Man): Melorheostosis
- PubMed/NCBI: Molecular insights into the pathogenesis of Melorheostosis
